Go Pro

BlueLinx (BXC) Financials

BlueLinx logo
$56.63 -0.21 (-0.38%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$56.84 +0.22 (+0.39%)
As of 07/2/2026 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for BlueLinx

Annual Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders
-12 16 63 -48 -18 81 296 296 49 53 0.22
Consolidated Net Income / (Loss)
-12 16 63 -48 -18 81 296 296 49 53 0.22
Net Income / (Loss) Continuing Operations
-12 16 63 -48 -18 81 296 296 49 53 0.22
Total Pre-Tax Income
-11 17 9.59 -60 -22 95 394 395 82 71 0.13
Total Operating Income
16 42 30 -13 35 142 438 439 138 88 32
Total Gross Profit
222 227 231 332 357 478 778 833 527 489 452
Total Revenue
1,917 1,881 1,816 2,863 2,637 3,097 4,277 4,450 3,136 2,953 2,954
Operating Revenue
1,917 1,881 1,816 2,863 2,637 3,097 4,277 4,450 3,136 2,953 2,954
Total Cost of Revenue
1,694 1,654 1,585 2,531 2,280 2,620 3,499 3,617 2,609 2,463 2,502
Operating Cost of Revenue
1,694 1,654 1,585 2,531 2,280 2,620 3,499 3,617 2,609 2,463 2,502
Total Operating Expenses
206 186 201 345 322 335 344 394 389 402 419
Selling, General & Admin Expense
196 205 199 319 309 321 325 370 360 367 383
Depreciation Expense
9.74 9.34 9.03 26 30 29 28 28 32 38 40
Other Operating Expenses / (Income)
- - - - -3.96 -4.01 - - -3.93 -3.93 -3.93
Other Special Charges / (Income)
0.00 -28 -6.70 0.00 -13 -11 -8.43 -0.14 0.00 -0.27 0.00
Total Other Income / (Expense), net
-28 -24 -20 -47 -57 -47 -44 -44 -57 -17 -32
Interest & Investment Income
- - - - - - - -42 -24 -19 -32
Other Income / (Expense), net
-0.50 0.45 0.82 0.38 -2.54 0.25 1.31 -2.05 -33 2.48 0.00
Income Tax Expense
0.15 1.12 -53 -12 -3.95 14 98 99 33 18 -0.09
Basic Earnings per Share
($1.32) $1.80 $6.96 ($5.21) ($1.89) $8.58 $30.80 $31.75 $5.40 $6.22 $0.02
Weighted Average Basic Shares Outstanding
8.75M 8.91M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Diluted Earnings per Share
($1.32) $1.77 $6.81 ($5.21) ($1.89) $8.55 $29.99 $31.51 $5.39 $6.19 $0.02
Weighted Average Diluted Shares Outstanding
8.75M 8.91M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Weighted Average Basic & Diluted Shares Outstanding
8.75M 8.91M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M

Quarterly Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026
Net Income / (Loss) Attributable to Common Shareholders
24 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46
Consolidated Net Income / (Loss)
24 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46
Net Income / (Loss) Continuing Operations
24 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46
Total Pre-Tax Income
33 -8.02 23 19 22 6.97 4.14 6.58 1.36 -12 -1.82
Total Operating Income
40 27 28 24 24 12 11 15 9.97 -3.24 7.33
Total Gross Profit
139 118 128 122 126 113 111 120 108 113 116
Total Revenue
810 713 726 768 747 711 709 780 749 716 731
Operating Revenue
810 713 726 768 747 711 709 780 749 716 731
Total Cost of Revenue
671 594 599 646 622 597 598 660 641 603 615
Operating Cost of Revenue
671 594 599 646 622 597 598 660 641 603 615
Total Operating Expenses
100 91 100 99 102 101 100 105 98 116 109
Selling, General & Admin Expense
92 84 91 89 92 93 94 95 89 105 96
Depreciation Expense
8.09 8.29 9.43 10 9.53 9.41 9.55 9.79 9.74 11 12
Other Operating Expenses / (Income)
-0.98 -0.98 -0.67 -0.98 -0.10 -0.98 -3.24 -0.40 -0.80 0.51 0.89
Total Other Income / (Expense), net
-6.17 -35 -4.62 -4.80 -2.39 -5.07 -6.58 -8.46 -8.60 -8.71 -9.15
Interest & Investment Income
-5.58 - -4.62 -4.80 -4.62 - -6.58 -8.46 -8.60 -8.71 -9.15
Income Tax Expense
9.10 10 5.55 4.71 5.62 1.69 1.34 2.27 -0.29 -3.41 -0.36
Basic Earnings per Share
$2.72 ($1.98) $2.02 $1.65 $1.88 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18)
Weighted Average Basic Shares Outstanding
8.77M 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M
Diluted Earnings per Share
$2.71 ($1.96) $2.00 $1.65 $1.87 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18)
Weighted Average Diluted Shares Outstanding
8.77M 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M
Weighted Average Basic & Diluted Shares Outstanding
8.77M 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M

Annual Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents
0.29 0.73 -0.84 4.24 2.70 -12 85 214 223 -16 -120
Net Cash From Operating Activities
40 41 -2.50 42 -10 55 145 400 306 85 60
Net Cash From Continuing Operating Activities
40 41 -2.50 42 -10 55 145 400 306 85 60
Net Income / (Loss) Continuing Operations
-12 16 63 -48 -18 81 296 296 49 53 0.22
Consolidated Net Income / (Loss)
-12 16 63 -48 -18 81 296 296 49 53 0.22
Depreciation Expense
9.74 9.34 9.03 26 30 29 28 28 32 38 40
Amortization Expense
2.99 2.69 0.60 -2.19 3.32 3.88 -2.52 -2.78 1.32 1.32 1.51
Non-Cash Adjustments To Reconcile Net Income
0.74 -24 -52 4.82 -15 -8.55 5.56 9.47 38 3.54 4.88
Changes in Operating Assets and Liabilities, net
38 37 -23 61 -11 -50 -182 70 187 -11 13
Net Cash From Investing Activities
-0.80 37 27 -243 21 9.16 -4.09 -99 -27 -39 -119
Net Cash From Continuing Investing Activities
-0.80 37 27 -243 21 9.16 -4.09 -99 -27 -39 -119
Purchase of Property, Plant & Equipment
-1.56 -0.63 -0.80 -2.72 -4.79 -3.69 -14 -36 -28 -40 -27
Acquisitions
- 0.00 0.00 -348 - 0.00 0.00 -64 0.30 0.00 -95
Other Investing Activities, net
- - - - - - - - 0.36 0.90 2.66
Net Cash From Financing Activities
-39 -78 -25 205 -8.14 -76 -56 -88 -57 -62 -60
Net Cash From Continuing Financing Activities
-39 -78 -25 205 -8.14 -76 -56 -88 -57 -62 -60
Repayment of Debt
-447 -565 -468 -852 -693 -989 -335 - 0.00 0.00 -3.10
Repurchase of Common Equity
- - - - - 0.00 0.00 -66 -42 -45 -38
Other Financing Activities, net
-0.46 -0.18 -0.23 -3.02 35 69 -16 -21 -14 -17 -19
Cash Interest Paid
24 21 20 37 47 44 33 44 43 45 47
Cash Income Taxes Paid
0.69 0.63 1.58 2.64 2.99 14 99 111 19 30 3.99

Quarterly Cash Flow Statements for BlueLinx

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026
Net Change in Cash & Equivalents
51 52 -40 10 35 -21 -57 -62 43 -44 -67
Net Cash From Operating Activities
78 76 -31 36 62 19 -34 -27 59 62 -57
Net Cash From Continuing Operating Activities
78 76 -31 36 62 19 -34 -27 59 62 -57
Net Income / (Loss) Continuing Operations
24 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46
Consolidated Net Income / (Loss)
24 -18 17 14 16 5.27 2.81 4.31 1.66 -8.55 -1.46
Depreciation Expense
8.09 8.29 9.43 10 9.53 9.41 9.55 9.79 9.74 11 12
Amortization Expense
-0.65 -0.65 -0.65 -0.65 -0.65 -0.65 0.33 -0.65 -0.51 3.33 0.39
Non-Cash Adjustments To Reconcile Net Income
2.98 32 2.35 1.41 0.96 2.76 -0.91 2.34 3.45 -1.00 2.11
Changes in Operating Assets and Liabilities, net
43 54 -60 11 36 1.96 -46 -43 44 57 -70
Net Cash From Investing Activities
-4.84 -8.12 -5.32 -6.31 -7.36 -20 -3.39 -9.54 -5.93 -101 -1.72
Net Cash From Continuing Investing Activities
-4.84 -8.12 -5.32 -6.31 -7.36 -20 -3.39 -9.54 -5.93 -101 -1.72
Purchase of Property, Plant & Equipment
-4.90 -8.58 -5.45 -6.45 -7.93 -20 -5.93 -9.61 -5.95 -5.45 -2.60
Divestitures
- - - - - - 0.00 - - - 0.86
Other Investing Activities, net
- - 0.13 - - - 2.54 0.07 0.02 0.03 0.02
Net Cash From Financing Activities
-21 -15 -3.98 -19 -20 -19 -19 -26 -10 -4.73 -7.81
Net Cash From Continuing Financing Activities
-21 -15 -3.98 -19 -20 -19 -19 -26 -10 -4.73 -7.81
Repayment of Debt
- - - - - - 0.00 - - -0.48 -0.13
Repurchase of Common Equity
-18 -13 0.00 - -15 -15 -15 -20 -2.74 - -2.75
Other Financing Activities, net
-3.59 -2.67 -3.98 -4.88 -4.06 -3.87 -4.30 -5.57 -4.74 -4.24 -4.93
Cash Interest Paid
6.48 15 6.80 15 6.88 16 7.16 16 7.16 17 7.13
Cash Income Taxes Paid
6.86 1.56 1.34 21 2.13 6.18 -1.08 4.63 0.40 0.04 -0.05

Annual Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets
513 444 494 960 971 1,048 1,317 1,490 1,538 1,578 1,549
Total Current Assets
402 346 343 600 578 668 945 1,077 1,120 1,134 984
Cash & Equivalents
4.81 5.54 4.70 8.94 12 0.08 85 299 522 506 386
Accounts Receivable
139 126 134 208 193 294 340 252 228 226 218
Inventories, net
227 191 188 342 346 342 488 484 344 356 326
Other Current Assets
32 23 17 41 28 33 32 42 27 47 54
Plant, Property, & Equipment, net
102 88 84 205 0.00 0.00 0.00 206 226 250 287
Plant, Property & Equipment, gross
209 190 187 308 - - - - - - 495
Accumulated Depreciation
107 102 103 103 - - - - - - 209
Total Noncurrent Assets
9.54 10 67 155 393 380 372 208 191 194 278
Goodwill
- - 0.00 48 48 48 48 55 55 55 67
Intangible Assets
- - 0.00 35 26 19 14 35 31 27 87
Noncurrent Deferred & Refundable Income Taxes
- 0.00 54 53 54 63 60 56 53 51 51
Other Noncurrent Operating Assets
9.54 10 13 19 265 250 251 61 52 61 74
Total Liabilities & Shareholders' Equity
513 444 494 960 971 1,048 1,317 1,490 1,538 1,578 1,549
Total Liabilities
559 474 459 975 998 989 954 900 903 931 932
Total Current Liabilities
130 154 118 197 171 229 244 211 219 234 211
Accounts Payable
88 83 71 149 132 165 180 152 158 170 136
Current Deferred Revenue
- - - - 3.94 4.04 3.93 3.94 3.94 3.94 3.94
Current Employee Benefit Liabilities
4.17 8.35 9.23 7.97 7.64 25 22 23 14 17 17
Other Current Liabilities
31 34 34 30 25 26 31 33 42 43 53
Total Noncurrent Liabilities
429 320 341 778 826 760 710 689 685 698 721
Long-Term Debt
378 271 277 498 458 321 291 292 294 295 297
Other Noncurrent Operating Liabilities
14 14 9.96 24 345 416 408 397 391 402 424
Commitments & Contingencies
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-46 -30 35 -15 -26 59 363 590 634 646 617
Total Preferred & Common Equity
-46 -30 35 -15 -26 59 363 590 634 646 617
Preferred Stock
- - - - - - - 0.00 0.00 0.00 0.00
Total Common Equity
-46 -30 35 -15 -26 59 363 590 634 646 617
Common Stock
256 258 260 259 261 267 268 201 165 124 95
Retained Earnings
-267 -251 -188 -236 -253 -172 124 421 469 522 522

Quarterly Balance Sheets for BlueLinx

This table presents BlueLinx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/1/2022 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026
Total Assets
1,534 1,526 1,550 1,585 1,592 1,586 1,611 1,633 1,584 1,582 1,598
Total Current Assets
1,158 1,114 1,137 1,171 1,173 1,159 1,181 1,166 1,105 1,099 1,045
Cash & Equivalents
229 376 418 470 481 491 526 449 387 429 319
Accounts Receivable
361 299 294 298 288 274 278 276 279 269 297
Inventories, net
536 409 379 364 371 358 341 400 391 346 372
Other Current Assets
32 29 45 40 32 36 37 42 48 55 57
Plant, Property, & Equipment, net
189 208 210 216 231 232 236 275 281 287 280
Plant, Property & Equipment, gross
340 366 374 382 407 414 424 462 475 488 497
Accumulated Depreciation
151 158 163 166 176 182 188 187 194 201 217
Total Noncurrent Assets
187 204 203 199 188 195 194 192 198 196 274
Goodwill
48 55 55 55 55 55 55 55 55 55 66
Intangible Assets
11 34 33 32 30 29 28 26 25 24 85
Noncurrent Deferred & Refundable Income Taxes
61 56 56 55 54 54 51 51 52 48 52
Other Noncurrent Operating Assets
66 59 59 57 49 57 59 60 66 68 71
Total Liabilities & Shareholders' Equity
1,534 1,526 1,550 1,585 1,592 1,586 1,611 1,633 1,584 1,582 1,598
Total Liabilities
976 915 928 954 938 934 955 997 963 959 983
Total Current Liabilities
273 228 245 268 249 237 258 281 243 239 268
Accounts Payable
208 177 190 202 172 179 186 213 178 169 195
Current Deferred Revenue
- 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94 3.94
Current Employee Benefit Liabilities
18 15 16 21 14 12 18 14 12 10 11
Other Current Liabilities
40 32 34 41 60 42 49 50 48 56 58
Total Noncurrent Liabilities
703 687 683 686 689 696 698 717 720 720 715
Long-Term Debt
292 293 293 293 294 294 295 295 296 296 297
Other Noncurrent Operating Liabilities
330 394 390 393 395 402 403 421 424 423 418
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
558 611 623 632 653 652 656 636 621 623 616
Total Preferred & Common Equity
558 611 623 632 653 652 656 636 621 623 616
Preferred Stock
- - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
558 611 623 632 653 652 656 636 621 623 616
Common Stock
198 204 191 175 167 151 139 111 92 92 95
Retained Earnings
389 438 463 487 487 501 517 525 529 531 521

Annual Metrics And Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
DEI Shares Outstanding
89,439,556.00 9,031,263.00 9,098,221.00 9,293,794.00 9,364,959.00 9,461,540.00 9,706,685.00 - - - 7,865,058.00
DEI Adjusted Shares Outstanding
8,943,956.00 9,031,263.00 9,098,221.00 9,293,794.00 9,364,959.00 9,461,540.00 9,706,685.00 - - - 7,865,058.00
DEI Earnings Per Adjusted Shares Outstanding
-1.29 1.78 6.92 -5.17 -1.89 8.55 30.51 - - - 0.03
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.17% -1.85% -3.48% 57.69% -7.88% 17.44% 38.09% 4.05% -29.52% -5.86% 0.05%
EBITDA Growth
10.87% 88.95% -25.29% -73.46% 516.35% 164.91% 165.32% -0.69% -70.76% -6.77% -43.09%
EBIT Growth
20.50% 164.49% -26.82% -141.89% 352.67% 336.97% 208.35% -0.53% -75.83% -14.75% -63.93%
NOPAT Growth
21.28% 238.85% 406.15% -104.72% 364.59% 391.71% 172.20% 0.02% -75.09% -19.81% -16.20%
Net Income Growth
16.55% 238.95% 291.63% -176.28% 63.26% 558.10% 266.13% 0.01% -83.61% 9.44% -99.59%
EPS Growth
16.55% 234.09% 284.75% -176.51% 63.72% 552.38% 250.76% 5.07% -82.89% 14.84% -99.68%
Operating Cash Flow Growth
424.58% 3.68% -106.05% 1,760.25% -124.80% 633.96% 163.59% 176.02% -23.49% -72.19% -29.81%
Free Cash Flow Firm Growth
23.56% 168.01% 17.82% -405.19% 181.27% -48.41% -12.89% 122.79% -17.75% -86.04% -202.48%
Invested Capital Growth
-7.92% -20.62% 26.48% 112.86% -40.70% -9.80% 49.25% 2.49% -30.37% 7.28% 21.16%
Revenue Q/Q Growth
-1.34% -0.34% 0.66% 9.11% -2.19% 8.86% 2.58% -2.74% -4.13% -0.06% 0.18%
EBITDA Q/Q Growth
33.57% 39.14% -22.15% -42.64% 17.93% 21.06% 19.01% -11.47% -29.37% 15.88% -11.79%
EBIT Q/Q Growth
32.68% 44.05% -28.07% -692.75% 25.19% 27.91% 22.17% -12.29% -34.96% 21.83% -31.98%
NOPAT Q/Q Growth
29.67% 1,156.77% 399.96% -508.61% 36.58% 27.31% 19.62% -11.43% -33.09% 20.05% 56.66%
Net Income Q/Q Growth
12.00% 4,789.50% 216.97% -322.42% 25.29% 59.13% 22.18% -12.32% -50.80% 78.72% -98.44%
EPS Q/Q Growth
12.00% 4,525.00% 212.39% -324.57% 25.59% 62.55% 20.78% -8.43% -54.36% 73.88% -98.85%
Operating Cash Flow Q/Q Growth
-2.92% 4.13% -176.10% 276.70% -116.30% -45.91% 34.93% 51.51% -20.44% -40.01% 258.12%
Free Cash Flow Firm Q/Q Growth
10.43% 12.49% 113.13% 26.72% 6.79% -24.83% 21.51% 22.70% -27.83% -57.85% -20.24%
Invested Capital Q/Q Growth
-18.25% -14.20% 16.10% -12.58% -21.53% -8.71% -1.29% -15.65% -10.73% 2.79% 7.76%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
11.61% 12.09% 12.73% 11.59% 13.53% 15.42% 18.20% 18.72% 16.80% 16.57% 15.29%
EBITDA Margin
1.49% 2.88% 2.23% 0.38% 2.51% 5.66% 10.87% 10.38% 4.31% 4.26% 2.50%
Operating Margin
0.86% 2.21% 1.65% -0.46% 1.33% 4.59% 10.24% 9.87% 4.41% 2.97% 1.10%
EBIT Margin
0.83% 2.24% 1.70% -0.45% 1.24% 4.60% 10.27% 9.82% 3.37% 3.05% 1.10%
Profit (Net Income) Margin
-0.60% 0.86% 3.47% -1.68% -0.67% 2.61% 6.92% 6.66% 1.55% 1.80% 0.01%
Tax Burden Percent
101.34% 93.48% 657.21% 79.81% 81.71% 85.07% 75.18% 75.03% 59.27% 75.14% 169.77%
Interest Burden Percent
-71.76% 40.87% 31.11% 466.50% -66.26% 66.73% 89.64% 90.33% 77.52% 78.50% 0.40%
Effective Tax Rate
0.00% 6.52% -557.21% 0.00% 0.00% 14.93% 24.82% 24.97% 40.73% 24.86% -69.77%
Return on Invested Capital (ROIC)
3.30% 13.01% 65.71% -1.77% 4.33% 30.09% 69.28% 57.15% 16.58% 15.63% 11.44%
ROIC Less NNEP Spread (ROIC-NNEP)
-2.63% 6.23% 20.61% -9.32% -2.85% 19.68% 56.71% 23.82% 45.17% 21.41% 48.09%
Return on Net Nonoperating Assets (RNNOA)
24.96% -55.49% 2,375.45% -470.75% 82.33% 459.97% 70.95% 4.99% -8.65% -7.33% -11.41%
Return on Equity (ROE)
28.26% -42.48% 2,441.15% -472.52% 86.66% 490.06% 140.23% 62.14% 7.93% 8.29% 0.03%
Cash Return on Invested Capital (CROIC)
11.55% 36.00% 42.32% -73.92% 55.43% 40.39% 29.77% 54.69% 52.39% 8.60% -7.70%
Operating Return on Assets (OROA)
3.03% 8.80% 6.57% -1.78% 3.38% 14.11% 37.15% 31.13% 6.98% 5.78% 2.08%
Return on Assets (ROA)
-2.21% 3.36% 13.43% -6.61% -1.83% 8.01% 25.04% 21.10% 3.21% 3.41% 0.01%
Return on Common Equity (ROCE)
28.26% -42.48% 2,441.15% -472.52% 86.66% 490.06% 140.23% 62.14% 7.93% 8.29% 0.03%
Return on Equity Simple (ROE_SIMPLE)
25.22% -53.90% 179.97% 327.72% 67.69% 136.87% 81.52% 50.20% 7.65% 8.22% 0.00%
Net Operating Profit after Tax (NOPAT)
11 39 197 -9.30 25 121 329 329 82 66 55
NOPAT Margin
0.60% 2.07% 10.86% -0.32% 0.93% 3.91% 7.70% 7.40% 2.62% 2.23% 1.87%
Net Nonoperating Expense Percent (NNEP)
5.93% 6.78% 45.09% 7.54% 7.18% 10.40% 12.58% 33.33% -28.59% -5.79% -36.65%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 37.33% 8.84% 6.99% 6.03%
Cost of Revenue to Revenue
88.39% 87.91% 87.27% 88.41% 86.47% 84.58% 81.80% 81.28% 83.20% 83.43% 84.71%
SG&A Expenses to Revenue
10.24% 10.87% 10.94% 11.15% 11.70% 10.37% 7.59% 8.32% 11.49% 12.44% 12.97%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.75% 9.88% 11.07% 12.06% 12.20% 10.83% 8.05% 8.85% 12.39% 13.60% 14.19%
Earnings before Interest and Taxes (EBIT)
16 42 31 -13 33 142 439 437 106 90 32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
29 54 40 11 66 175 465 462 135 126 74
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.54 0.00 0.00 4.69 2.56 1.09 1.57 1.34 0.77
Price to Tangible Book Value (P/TBV)
0.00 0.00 2.54 0.00 0.00 0.00 3.08 1.29 1.81 1.54 1.03
Price to Revenue (P/Rev)
0.02 0.04 0.05 0.08 0.05 0.09 0.22 0.14 0.32 0.29 0.16
Price to Earnings (P/E)
0.00 4.19 1.41 0.00 0.00 3.42 3.14 2.17 20.47 16.37 2,181.75
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 23.84% 70.94% 0.00% 0.00% 29.22% 31.86% 46.10% 4.89% 6.11% 0.05%
Enterprise Value to Invested Capital (EV/IC)
1.28 1.37 1.16 1.35 1.35 1.57 1.99 1.09 1.88 1.51 0.74
Enterprise Value to Revenue (EV/Rev)
0.22 0.19 0.21 0.34 0.22 0.19 0.27 0.14 0.24 0.22 0.13
Enterprise Value to EBITDA (EV/EBITDA)
14.90 6.69 9.61 89.71 8.65 3.42 2.44 1.38 5.67 5.23 5.26
Enterprise Value to EBIT (EV/EBIT)
26.82 8.60 12.62 0.00 17.54 4.21 2.58 1.46 7.25 7.31 11.96
Enterprise Value to NOPAT (EV/NOPAT)
37.16 9.30 1.97 0.00 23.25 4.95 3.45 1.93 9.33 10.01 7.05
Enterprise Value to Operating Cash Flow (EV/OCF)
10.69 8.75 0.00 23.17 0.00 10.89 7.83 1.59 2.50 7.73 6.50
Enterprise Value to Free Cash Flow (EV/FCFF)
10.62 3.36 3.06 0.00 1.82 3.69 8.03 2.02 2.95 18.19 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-8.38 -10.06 8.71 -50.24 -17.66 5.46 0.80 0.50 0.46 0.46 0.48
Long-Term Debt to Equity
-8.23 -9.07 8.60 -49.61 -17.58 5.44 0.80 0.50 0.46 0.46 0.48
Financial Leverage
-9.50 -8.90 115.24 50.53 -28.88 23.37 1.25 0.21 -0.19 -0.34 -0.24
Leverage Ratio
-12.81 -12.64 181.79 71.49 -47.40 61.18 5.60 2.95 2.47 2.43 2.47
Compound Leverage Factor
9.19 -5.17 56.56 333.49 31.41 40.82 5.02 2.66 1.92 1.91 0.01
Debt to Total Capital
113.56% 111.04% 89.70% 102.03% 106.00% 84.51% 44.50% 33.14% 31.65% 31.34% 32.46%
Short-Term Debt to Total Capital
1.95% 10.90% 1.05% 1.29% 0.50% 0.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
111.61% 100.14% 88.65% 100.74% 105.50% 84.21% 44.50% 33.14% 31.65% 31.34% 32.46%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-13.56% -11.04% 10.30% -2.03% -6.00% 15.49% 55.50% 66.86% 68.35% 68.66% 67.54%
Debt to EBITDA
13.42 5.55 7.53 68.63 6.96 1.84 0.63 0.63 2.17 2.34 4.01
Net Debt to EBITDA
13.25 5.44 7.42 67.80 6.79 1.84 0.44 -0.01 -1.69 -1.67 -1.21
Long-Term Debt to EBITDA
13.19 5.00 7.45 67.76 6.93 1.83 0.63 0.63 2.17 2.34 4.01
Debt to NOPAT
33.45 7.71 1.55 -79.22 18.72 2.66 0.88 0.89 3.58 4.48 5.38
Net Debt to NOPAT
33.03 7.57 1.52 -78.26 18.25 2.66 0.63 -0.02 -2.78 -3.20 -1.62
Long-Term Debt to NOPAT
32.88 6.95 1.53 -78.22 18.63 2.66 0.88 0.89 3.58 4.48 5.38
Altman Z-Score
3.80 4.36 4.01 3.24 3.04 3.85 5.70 5.48 4.06 3.77 3.35
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.09 2.24 2.92 3.05 3.38 2.92 3.88 5.11 5.13 4.85 4.66
Quick Ratio
1.10 0.85 1.18 1.10 1.20 1.28 1.74 2.61 3.43 3.13 2.86
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
40 108 127 -387 315 162 141 315 259 36 -37
Operating Cash Flow to CapEx
4,984.64% 0.00% 0.00% 0.00% 0.00% 0.00% 3,547.53% 1,146.26% 1,127.58% 217.24% 221.97%
Free Cash Flow to Firm to Interest Expense
1.47 4.33 5.98 -8.19 5.81 3.43 3.11 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
1.46 1.66 -0.12 0.88 -0.19 1.16 3.19 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
1.43 3.14 1.15 3.11 0.09 1.35 3.10 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
3.65 3.93 3.87 3.94 2.73 3.07 3.62 3.17 2.07 1.90 1.89
Accounts Receivable Turnover
13.54 14.23 13.97 16.72 13.14 12.73 13.51 15.06 13.07 13.00 13.31
Inventory Turnover
7.22 7.91 8.37 9.56 6.63 7.62 8.43 7.44 6.30 7.04 7.34
Fixed Asset Turnover
18.53 19.81 21.10 19.82 0.00 0.00 0.00 0.00 14.53 12.42 11.02
Accounts Payable Turnover
21.81 19.36 20.66 23.03 16.20 17.61 20.27 21.82 16.86 15.01 16.32
Days Sales Outstanding (DSO)
26.96 25.65 26.13 21.83 27.77 28.67 27.02 24.24 27.93 28.08 27.43
Days Inventory Outstanding (DIO)
50.55 46.13 43.63 38.17 55.03 47.93 43.32 49.08 57.91 51.83 49.73
Days Payable Outstanding (DPO)
16.74 18.85 17.66 15.85 22.53 20.73 18.00 16.73 21.65 24.31 22.36
Cash Conversion Cycle (CCC)
60.76 52.93 52.09 44.15 60.27 55.86 52.34 56.59 64.18 55.59 54.80
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
334 265 335 713 423 381 569 584 406 436 528
Invested Capital Turnover
5.51 6.29 6.05 5.46 4.64 7.70 9.00 7.72 6.34 7.01 6.13
Increase / (Decrease) in Invested Capital
-29 -69 70 378 -290 -41 188 14 -177 30 92
Enterprise Value (EV)
427 362 389 963 572 599 1,136 636 765 659 389
Market Capitalization
47 67 89 235 123 277 930 643 993 869 478
Book Value per Share
($0.51) ($3.30) $3.85 ($1.58) ($2.79) $6.25 $37.42 $65.30 $72.35 $77.13 $78.49
Tangible Book Value per Share
($0.51) ($3.30) $3.85 ($10.51) ($10.70) ($0.80) $31.10 $55.30 $62.52 $67.32 $58.92
Total Capital
338 270 340 722 435 382 655 882 928 942 914
Total Debt
384 300 305 737 461 322 291 292 294 295 297
Total Long-Term Debt
378 271 301 727 458 321 291 292 294 295 297
Net Debt
380 295 300 728 449 322 206 -6.52 -228 -211 -89
Capital Expenditures (CapEx)
0.80 -37 -27 -105 -15 -9.16 4.09 35 27 39 27
Debt-free, Cash-free Net Working Capital (DFCFNWC)
274 215 225 403 397 440 616 567 380 395 387
Debt-free Net Working Capital (DFNWC)
278 221 229 412 409 441 701 866 902 900 773
Net Working Capital (NWC)
272 191 226 403 407 439 701 866 902 900 773
Net Nonoperating Expense (NNE)
23 23 134 39 42 40 33 33 34 13 55
Net Nonoperating Obligations (NNO)
380 295 300 728 449 322 206 -6.52 -228 -211 -89
Total Depreciation and Amortization (D&A)
13 12 9.63 24 34 33 26 25 29 36 41
Debt-free, Cash-free Net Working Capital to Revenue
14.28% 11.45% 12.37% 14.09% 15.07% 14.22% 14.41% 12.75% 12.12% 13.37% 13.11%
Debt-free Net Working Capital to Revenue
14.53% 11.75% 12.63% 14.40% 15.51% 14.22% 16.40% 19.47% 28.75% 30.49% 26.17%
Net Working Capital to Revenue
14.18% 10.18% 12.44% 14.08% 15.43% 14.19% 16.40% 19.47% 28.75% 30.49% 26.17%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.30) $1.80 $6.96 ($5.21) ($1.89) $8.58 $30.80 $31.75 $5.40 $6.22 $0.02
Adjusted Weighted Average Basic Shares Outstanding
9.01M 9.01M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Adjusted Diluted Earnings per Share
($1.30) $1.77 $6.81 ($5.21) ($1.89) $8.55 $29.99 $31.51 $5.39 $6.19 $0.02
Adjusted Weighted Average Diluted Shares Outstanding
9.01M 9.01M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Adjusted Basic & Diluted Earnings per Share
($1.30) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.75M 9.01M 9.14M 9.34M 9.37M 9.47M 9.73M 9.06M 8.65M 8.29M 7.87M
Normalized Net Operating Profit after Tax (NOPAT)
11 13 16 -9.30 15 112 323 329 82 66 23
Normalized NOPAT Margin
0.60% 0.67% 0.90% -0.32% 0.59% 3.62% 7.55% 7.40% 2.62% 2.22% 0.77%
Pre Tax Income Margin
-0.60% 0.91% 0.53% -2.10% -0.82% 3.07% 9.21% 8.87% 2.61% 2.39% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.58 1.69 1.45 -0.27 0.60 3.01 9.66 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.42 1.56 9.29 -0.20 0.45 2.55 7.24 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.55 3.17 2.72 1.95 0.88 3.20 9.57 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.39 3.04 10.55 2.03 0.73 2.75 7.15 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 22.43% 86.81% 85.28% 17,409.13%

Quarterly Metrics And Ratios for BlueLinx

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026
DEI Shares Outstanding
- - - - - - - 8,022,223.00 7,892,416.00 7,865,058.00 7,866,824.00
DEI Adjusted Shares Outstanding
- - - - - - - 8,022,223.00 7,892,416.00 7,865,058.00 7,866,824.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.54 0.21 -1.09 -0.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-23.64% -15.95% -8.98% -5.83% -7.74% -0.27% -2.34% 1.53% 0.21% 0.73% 3.09%
EBITDA Growth
-52.13% -93.49% -6.51% -27.26% -24.45% 456.07% -46.15% -27.44% -45.35% -55.89% -4.46%
EBIT Growth
-57.12% -107.53% -13.32% -38.06% -32.80% 419.09% -61.24% -36.95% -62.04% -126.95% -31.67%
NOPAT Growth
-56.87% -52.63% -12.12% -39.59% -38.40% -52.15% -65.44% -45.12% -31.97% -124.92% -29.33%
Net Income Growth
-59.03% -156.66% -1.80% -41.40% -34.31% 129.09% -83.96% -69.94% -89.67% -262.20% -151.98%
EPS Growth
-57.52% -143.95% 3.09% -38.89% -31.00% 134.18% -83.50% -67.27% -89.30% -256.72% -154.55%
Operating Cash Flow Growth
-45.58% -51.02% -135.00% -44.19% -20.41% -75.19% -8.91% -174.74% -5.10% 229.89% -68.77%
Free Cash Flow Firm Growth
652.09% 655.55% -60.04% -79.34% -81.59% -110.44% -111.23% -208.22% -210.37% -361.35% -1,043.75%
Invested Capital Growth
-34.21% -30.37% -11.62% -8.48% -6.83% 7.28% 3.54% 16.46% 15.58% 21.16% 22.97%
Revenue Q/Q Growth
-0.73% -12.03% 1.92% 5.80% -2.74% -4.90% -0.20% 9.99% -4.00% -4.42% 2.14%
EBITDA Q/Q Growth
1.53% -91.86% 863.44% -8.60% 5.45% -40.11% -6.70% 23.16% -20.58% -43.20% 80.60%
EBIT Q/Q Growth
1.46% -109.86% 818.65% -13.81% 10.08% -53.20% -12.71% 40.20% -33.71% -132.53% 326.03%
NOPAT Q/Q Growth
-2.82% -34.10% 10.37% -14.53% -0.90% -48.81% -20.28% 35.71% 22.84% -118.75% 326.03%
Net Income Q/Q Growth
-0.34% -174.33% 196.51% -18.04% 11.72% -67.08% -46.79% 53.65% -61.60% -616.68% 82.95%
EPS Q/Q Growth
0.37% -172.32% 202.04% -17.50% 13.33% -64.17% -50.75% 63.64% -62.96% -625.00% 82.86%
Operating Cash Flow Q/Q Growth
20.97% -2.64% -141.21% 214.99% 72.52% -69.65% -280.90% 21.09% 319.06% 5.49% -192.55%
Free Cash Flow Firm Q/Q Growth
-8.76% -26.09% -58.07% -26.92% -18.70% -141.91% 54.89% -604.05% 17.08% -75.17% -11.85%
Invested Capital Q/Q Growth
-8.52% -10.73% 14.69% -2.28% -6.87% 2.79% 10.69% 9.90% -7.58% 7.76% 12.35%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
17.19% 16.62% 17.58% 15.94% 16.82% 15.95% 15.67% 15.34% 14.45% 15.73% 15.92%
EBITDA Margin
5.74% 0.53% 5.02% 4.34% 4.70% 2.96% 2.77% 3.10% 2.56% 1.52% 2.69%
Operating Margin
4.90% 3.82% 3.81% 3.10% 3.22% 1.69% 1.51% 1.93% 1.33% -0.45% 1.00%
EBIT Margin
4.82% -0.54% 3.81% 3.10% 3.51% 1.73% 1.51% 1.93% 1.33% -0.45% 1.00%
Profit (Net Income) Margin
3.01% -2.54% 2.41% 1.87% 2.14% 0.74% 0.40% 0.55% 0.22% -1.19% -0.20%
Tax Burden Percent
72.81% 225.96% 75.91% 75.27% 74.04% 75.69% 67.69% 65.52% 121.42% 71.52% 80.15%
Interest Burden Percent
85.72% 208.34% 83.29% 79.87% 82.40% 56.70% 38.64% 43.75% 13.68% 368.78% -24.82%
Effective Tax Rate
27.19% 0.00% 24.09% 24.73% 25.96% 24.31% 32.31% 34.48% -21.42% 0.00% 0.00%
Return on Invested Capital (ROIC)
20.34% 16.93% 17.85% 14.79% 16.00% 8.98% 6.34% 7.55% 10.43% -1.94% 3.88%
ROIC Less NNEP Spread (ROIC-NNEP)
41.59% 48.61% 20.44% 17.04% 16.87% 10.73% 8.95% 11.40% 16.16% 2.25% 11.37%
Return on Net Nonoperating Assets (RNNOA)
-1.48% -9.31% -4.38% -4.31% -5.35% -3.68% -2.37% -2.58% -4.61% -0.53% -1.60%
Return on Equity (ROE)
18.86% 7.61% 13.47% 10.49% 10.65% 5.31% 3.97% 4.97% 5.82% -2.48% 2.28%
Cash Return on Invested Capital (CROIC)
62.65% 52.39% 28.41% 22.86% 19.54% 8.60% 7.57% -6.14% -6.75% -7.70% -16.82%
Operating Return on Assets (OROA)
10.12% -1.12% 7.49% 5.97% 6.49% 3.28% 2.75% 3.58% 2.46% -0.86% 1.85%
Return on Assets (ROA)
6.31% -5.27% 4.74% 3.59% 3.96% 1.41% 0.72% 1.03% 0.41% -2.26% -0.37%
Return on Common Equity (ROCE)
18.86% 7.61% 13.47% 10.49% 10.65% 5.31% 3.97% 4.97% 5.82% -2.48% 2.28%
Return on Equity Simple (ROE_SIMPLE)
15.62% 0.00% 7.38% 5.84% 4.53% 0.00% 6.04% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
29 19 21 18 18 9.11 7.26 9.85 12 -2.27 5.13
NOPAT Margin
3.56% 2.67% 2.89% 2.34% 2.38% 1.28% 1.02% 1.26% 1.62% -0.32% 0.70%
Net Nonoperating Expense Percent (NNEP)
-21.25% -31.68% -2.59% -2.24% -0.87% -1.75% -2.61% -3.85% -5.73% -4.19% -7.49%
Return On Investment Capital (ROIC_SIMPLE)
- 2.05% - - - 0.97% 0.78% 1.07% 1.32% -0.25% 0.56%
Cost of Revenue to Revenue
82.81% 83.38% 82.42% 84.06% 83.18% 84.05% 84.33% 84.66% 85.55% 84.27% 84.08%
SG&A Expenses to Revenue
11.42% 11.78% 12.61% 11.64% 12.46% 13.11% 13.27% 12.21% 11.92% 14.60% 13.16%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.30% 12.81% 13.77% 12.83% 13.60% 14.26% 14.16% 13.42% 13.12% 16.19% 14.92%
Earnings before Interest and Taxes (EBIT)
39 -3.85 28 24 26 12 11 15 9.97 -3.24 7.33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
46 3.78 36 33 35 21 20 24 19 11 20
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.17 1.57 1.75 1.24 1.36 1.34 1.00 0.96 0.94 0.77 0.66
Price to Tangible Book Value (P/TBV)
1.36 1.81 2.01 1.42 1.56 1.54 1.15 1.10 1.08 1.03 0.87
Price to Revenue (P/Rev)
0.23 0.32 0.37 0.27 0.30 0.29 0.22 0.20 0.20 0.16 0.14
Price to Earnings (P/E)
7.49 20.47 23.68 21.17 29.99 16.37 16.54 20.97 41.64 2,181.75 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
13.35% 4.89% 4.22% 4.72% 3.33% 6.11% 6.05% 4.77% 2.40% 0.05% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.24 1.88 2.05 1.34 1.56 1.51 1.00 0.95 0.92 0.74 0.65
Enterprise Value to Revenue (EV/Rev)
0.17 0.24 0.31 0.20 0.22 0.22 0.16 0.17 0.15 0.13 0.13
Enterprise Value to EBITDA (EV/EBITDA)
2.94 5.67 7.20 5.08 6.07 5.23 4.52 5.18 5.39 5.26 5.25
Enterprise Value to EBIT (EV/EBIT)
3.46 7.25 9.42 7.03 8.93 7.31 6.82 8.16 9.46 11.96 13.18
Enterprise Value to NOPAT (EV/NOPAT)
4.59 9.33 11.96 9.13 12.04 10.01 9.19 11.30 12.83 7.05 18.83
Enterprise Value to Operating Cash Flow (EV/OCF)
1.46 2.50 5.13 3.86 4.65 7.73 5.85 25.43 27.06 6.50 10.51
Enterprise Value to Free Cash Flow (EV/FCFF)
1.57 2.95 6.76 5.59 7.68 18.19 13.42 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.46 0.46 0.45 0.45 0.45 0.46 0.46 0.48 0.48 0.48 0.48
Long-Term Debt to Equity
0.46 0.46 0.45 0.45 0.45 0.46 0.46 0.48 0.48 0.48 0.48
Financial Leverage
-0.04 -0.19 -0.21 -0.25 -0.32 -0.34 -0.26 -0.23 -0.29 -0.24 -0.14
Leverage Ratio
2.62 2.47 2.47 2.46 2.48 2.43 2.50 2.49 2.50 2.47 2.58
Compound Leverage Factor
2.25 5.15 2.05 1.96 2.05 1.38 0.97 1.09 0.34 9.13 -0.64
Debt to Total Capital
31.72% 31.65% 31.04% 31.10% 31.01% 31.34% 31.71% 32.25% 32.24% 32.46% 32.54%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
31.72% 31.65% 31.04% 31.10% 31.01% 31.34% 31.71% 32.25% 32.24% 32.46% 32.54%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
68.28% 68.35% 68.96% 68.90% 68.99% 68.66% 68.29% 67.75% 67.76% 67.54% 67.46%
Debt to EBITDA
1.53 2.17 2.22 2.45 2.71 2.34 2.77 3.03 3.54 4.01 4.07
Net Debt to EBITDA
-0.92 -1.69 -1.41 -1.64 -2.13 -1.67 -1.44 -0.93 -1.59 -1.21 -0.30
Long-Term Debt to EBITDA
1.53 2.17 2.22 2.45 2.71 2.34 2.77 3.03 3.54 4.01 4.07
Debt to NOPAT
2.39 3.58 3.68 4.41 5.38 4.48 5.64 6.62 8.42 5.38 14.58
Net Debt to NOPAT
-1.44 -2.78 -2.35 -2.95 -4.22 -3.20 -2.93 -2.04 -3.78 -1.62 -1.09
Long-Term Debt to NOPAT
2.39 3.58 3.68 4.41 5.38 4.48 5.64 6.62 8.42 5.38 14.58
Altman Z-Score
3.72 3.82 3.84 3.61 3.58 3.61 3.30 3.38 3.37 3.28 3.16
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.37 5.13 4.71 4.88 4.58 4.85 4.16 4.55 4.60 4.66 3.90
Quick Ratio
2.86 3.43 3.09 3.22 3.12 3.13 2.58 2.74 2.92 2.86 2.30
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
266 196 82 60 49 -20 -9.24 -65 -54 -95 -106
Operating Cash Flow to CapEx
1,604.76% 897.83% -585.24% 567.67% 838.76% 92.70% -571.61% -278.53% 985.64% 1,135.19% -2,201.85%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 17.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 -6.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -7.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.10 2.07 1.97 1.92 1.85 1.90 1.82 1.86 1.85 1.89 1.84
Accounts Receivable Turnover
9.94 13.07 10.44 10.63 10.27 13.00 10.41 10.67 10.79 13.31 10.40
Inventory Turnover
6.03 6.30 6.52 6.81 6.98 7.04 6.39 6.61 7.27 7.34 6.53
Fixed Asset Turnover
16.19 14.53 13.96 13.63 13.09 12.42 11.59 11.49 11.28 11.02 10.73
Accounts Payable Turnover
13.21 16.86 14.59 13.58 12.66 15.01 12.80 13.87 14.07 16.32 12.34
Days Sales Outstanding (DSO)
36.71 27.93 34.96 34.35 35.56 28.08 35.05 34.20 33.83 27.43 35.10
Days Inventory Outstanding (DIO)
60.58 57.91 55.98 53.59 52.28 51.83 57.09 55.18 50.18 49.73 55.87
Days Payable Outstanding (DPO)
27.62 21.65 25.02 26.87 28.82 24.31 28.52 26.33 25.94 22.36 29.59
Cash Conversion Cycle (CCC)
69.67 64.18 65.92 61.07 59.01 55.59 63.63 63.05 58.07 54.80 61.38
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
455 406 466 455 424 436 482 530 490 528 593
Invested Capital Turnover
5.71 6.34 6.17 6.33 6.72 7.01 6.19 5.98 6.45 6.13 5.53
Increase / (Decrease) in Invested Capital
-237 -177 -61 -42 -31 30 17 75 66 92 111
Enterprise Value (EV)
563 765 955 609 660 659 482 505 452 389 383
Market Capitalization
739 993 1,142 806 891 869 635 596 585 478 406
Book Value per Share
$70.14 $72.35 $75.41 $75.31 $76.90 $77.13 $76.69 $77.45 $78.94 $78.49 $78.25
Tangible Book Value per Share
$60.46 $62.52 $65.59 $65.60 $67.14 $67.32 $66.89 $67.43 $68.88 $58.92 $59.05
Total Capital
925 928 947 947 950 942 932 917 919 914 912
Total Debt
293 294 294 294 295 295 295 296 296 297 297
Total Long-Term Debt
293 294 294 294 295 295 295 296 296 297 297
Net Debt
-176 -228 -187 -197 -232 -211 -154 -91 -133 -89 -22
Capital Expenditures (CapEx)
4.84 8.42 5.32 6.31 7.36 20 5.93 9.61 5.95 5.45 2.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
433 380 442 430 397 395 437 475 431 387 458
Debt-free Net Working Capital (DFNWC)
903 902 924 921 924 900 886 862 860 773 777
Net Working Capital (NWC)
903 902 924 921 924 900 886 862 860 773 777
Net Nonoperating Expense (NNE)
4.49 37 3.51 3.61 1.77 3.83 4.45 5.54 10 6.28 6.59
Net Nonoperating Obligations (NNO)
-176 -228 -187 -197 -232 -211 -154 -91 -133 -89 -22
Total Depreciation and Amortization (D&A)
7.44 7.63 8.78 9.47 8.88 8.75 8.90 9.14 9.23 14 12
Debt-free, Cash-free Net Working Capital to Revenue
13.25% 12.12% 14.43% 14.25% 13.45% 13.37% 14.88% 16.12% 14.60% 13.11% 15.38%
Debt-free Net Working Capital to Revenue
27.60% 28.75% 30.13% 30.53% 31.26% 30.49% 30.17% 29.24% 29.16% 26.17% 26.10%
Net Working Capital to Revenue
27.60% 28.75% 30.13% 30.53% 31.26% 30.49% 30.17% 29.24% 29.16% 26.17% 26.10%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.72 ($1.98) $2.02 $1.65 $1.88 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18)
Adjusted Weighted Average Basic Shares Outstanding
8.77M 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M
Adjusted Diluted Earnings per Share
$2.71 ($1.96) $2.00 $1.65 $1.87 $0.67 $0.33 $0.54 $0.20 ($1.05) ($0.18)
Adjusted Weighted Average Diluted Shares Outstanding
8.77M 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.77M 8.65M 8.66M 8.53M 8.38M 8.29M 8.02M 7.89M 7.87M 7.87M 7.78M
Normalized Net Operating Profit after Tax (NOPAT)
29 19 21 18 18 9.11 7.26 9.85 6.98 -2.27 5.13
Normalized NOPAT Margin
3.56% 2.67% 2.89% 2.34% 2.38% 1.28% 1.02% 1.26% 0.93% -0.32% 0.70%
Pre Tax Income Margin
4.13% -1.13% 3.17% 2.48% 2.89% 0.98% 0.58% 0.84% 0.18% -1.67% -0.25%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 5.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 4.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 4.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 3.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
29.72% 86.81% 0.00% 118.32% 144.00% 85.28% 156.92% 232.91% 380.58% 17,409.13% -639.76%

Financials Breakdown Chart

Key Financial Trends

BlueLinx Holdings Inc. (NYSE: BXC) entered 2026 with a much weaker first quarter than the same period a year ago. Revenue was still solid at $731.1 million, but the company posted a net loss of $1.5 million versus a profit in the prior-year quarter, and operating cash flow turned sharply negative. The balance sheet remains liquid, but earnings and cash generation have clearly cooled from the strong 2024–2025 period.

  • Revenue held up reasonably well year over year. Q1 2026 revenue was $731.1 million, up slightly from $709.2 million in Q1 2025.
  • BlueLinx still has a large cash cushion. Cash and equivalents were $319.1 million at the end of Q1 2026.
  • Leverage appears manageable for now. Long-term debt was $296.9 million, which is modest relative to total assets of $1.60 billion and equity of $615.5 million.
  • Gross profit remained positive and sizable. Q1 2026 gross profit was $116.4 million, showing the business still has earnings power when volumes and margins cooperate.
  • Inventory and receivables remain well supported by cash. The company ended the quarter with strong current assets of $1.04 billion.
  • Operating performance was roughly flat to slightly weaker at the margin. Gross profit improved year over year, but SG&A also stayed elevated at $96.2 million, leaving operating income only $7.3 million.
  • Seasonality is still evident. BlueLinx has posted very uneven quarterly results over the past several years, so one weak quarter does not by itself define the trend.
  • Share count has moved lower over time. Weighted average shares in Q1 2026 were 7.78 million, down from 8.02 million a year earlier, which can help EPS when profits recover.
  • Q1 2026 swung to a loss. Net income fell to -$1.46 million from $2.81 million in Q1 2025.
  • Operating cash flow was deeply negative. BlueLinx used $57.2 million in operating cash in Q1 2026, compared with negative $33.9 million in Q1 2025 and positive cash generation in several earlier quarters.
  • Working capital consumed a lot of cash. Changes in operating assets and liabilities reduced cash by $70.2 million in the quarter.
  • Interest burden remains meaningful. Cash interest paid was $7.1 million in Q1 2026, which is a notable drag when earnings are weak.
  • Cash declined sharply during the quarter. Cash and equivalents fell from $386.8 million in Q2 2025 to $319.1 million in Q1 2026, a drop of about $67.8 million.

Longer-term trend: BlueLinx’s results over the last four years show a cyclical distributor that can generate strong profits and cash flow in favorable conditions, but margins can deteriorate quickly when pricing or demand weakens. In 2023 and much of 2024, the company produced multiple strong quarters with robust operating cash flow. More recently, however, profitability has softened, and Q1 2026 suggests the business is under pressure again.

Bottom line: BlueLinx still has a healthy balance sheet and plenty of liquidity, but the latest quarter was disappointing because revenue growth did not translate into profits or cash generation. Investors will likely want to see improvement in operating margins and working-capital efficiency before the stock earns a more constructive trend call.

07/05/26 07:58 AM ETAI Generated. May Contain Errors.

BlueLinx Financials - Frequently Asked Questions

According to the most recent income statement we have on file, BlueLinx's financial year ends in January. Their financial year 2026 ended on January 3, 2026.

BlueLinx's net income appears to be on an upward trend, with a most recent value of $219 thousand in 2025, falling from -$11.58 million in 2015. The previous period was $53.12 million in 2024. View BlueLinx's forecast to see where analysts expect BlueLinx to go next.

BlueLinx's total operating income in 2025 was $32.48 million, based on the following breakdown:
  • Total Gross Profit: $451.63 million
  • Total Operating Expenses: $419.15 million

Over the last 10 years, BlueLinx's total revenue changed from $1.92 billion in 2015 to $2.95 billion in 2025, a change of 54.1%.

BlueLinx's total liabilities were at $931.96 million at the end of 2025, a 0.1% increase from 2024, and a 66.7% increase since 2015.

In the past 10 years, BlueLinx's cash and equivalents has ranged from $82 thousand in 2020 to $521.74 million in 2023, and is currently $385.84 million as of their latest financial filing in 2025.

Over the last 10 years, BlueLinx's book value per share changed from -0.51 in 2015 to 78.49 in 2025, a change of -15,393.9%.



Financial statements for NYSE:BXC last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners